Cory Taylor, MD January 15, 2016. 56 year-old veteran with obstructive sleep apnea presents with subacute abdominal pain. CT findings are concerning for.

Slides:



Advertisements
Similar presentations
Pain Control in Hospice and Palliative Care
Advertisements

Opioids and other drugs we use on palliative care
Transdermal pain management
Education and Training Module for Ohio EMS Developed in the 1960s Opioid antagonist Emergent overdose treatment in the hospital and prehospital settings.
Opioid Pharmacology: How to choose and how to use Romayne Gallagher MD, CCFP Division of Palliative Providence Health Care.
New Opioid Formulations: Hope on the Horizon Pamela P. Palmer, MD PhD Professor and Director, UCSF PainCARE Chief Medical Officer, AcelRx Pharmaceuticals,
OPIOIDS I. Where do they come from? / synthesized in 1803
Julie Latimer DANA NSW Drug & Alcohol Nurses Forum September 2014.
Key dosing points: Begin a bowel regimen when opioid therapy is initiated (senna + docusate). For CHRONIC pain, use a scheduled medication regimen. ( ex:
Calvin Lui, MD PGY2 February 8,  Common Opioid Agents and Good Starting Dosages  Opioid Conversion  Use of Patient Controlled Analgesia and Good.
Pain Morning Report Robin Staib, PharmD December 22, 2011.
Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.
Sublingual Buprenorphine and Pain
Fentanyl. Fentanyl Basics  First synthesized in Belgium in the 1950’s for anesthesia  Trade Name “Sublimaze”  It is a potent synthetic narcotic with.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 05: Relieving Pain and Providing Comfort.
Revised 5/2008 Pain Management Introduction for incoming Trainees. Includes UMHHC specific information. “clicking” will progress you thru the slide show.
OPIOIDS NIRALI PATEL (2009) Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology.
Prof. Krishna Boddu. MBBS, MD, DNB, FANZCA, MMEd MBBS, MD, DNB, FANZCA, MMEd University of Texas Health Sciences at Houston, Texas, USA University of Western.
August 16, 2015 Equianalgesia Opioid Calculator: JHH Applications Suzanne A Nesbit, PharmD, CPE Clinical Pharmacy Specialist, Pain Management Department.
Use of the Personal Therapy Manager With Prialt® (Ziconotide Intrathecal Infusion) for Patient-controlled Analgesia: Case Series Gladstone C. McDowell,
UMMS CRIT Module II: Opioid Usage in Older Adults Catherine DuBeau, MD Clinical Director of Geriatrics UMMS.
Step two: Moderate pain Tramadol Opioid combinations Acetaminophen or aspirin with Codeine Hydrocodone Oxycodone Plus/minus adjuvants Dose limiting toxicity.
Painkillers or people-killers? Painkillers can be divided into two groups, non-narcotic analgesics which can be purchased over the counter (Tylenol, Advil,
A logical method for hospital- based pain treatment Bob Arnold MD Institute to Enhance Palliative Care.
OPIOIDS I. Where do they come from? –poppy plant: from middle east and Asia –dried sap from plant is opium; cultivated annually BUT plant produces drug.
 72 M, acute femoral fracture. History of hip, knee OA. Uses Tylenol, ibuprofen.  Used Norco in the past very infrequently. Keeps an old bottle in the.
C C E E N N L L E E Pediatric Palliative Care Analgesics NSAIDs  Cyclooxygenase inhibition leads to interference with production of PGs (Cox-2)  Decreased.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Pain Management Laura Bergs FNP. Definition of Chronic Pain Anyone with pain greater than 3 months Anyone with pain greater than 3 months Pain An unpleasant.
Opiates. Opiates: what, exactly are they?!? Opiates are used to induce sleep and alleviate pain. They act as depressants to the central nervous system.
Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist.
Acute Pain Management Solomon Liao, M.D. Clinical Professor Director of Palliative Care Service UCI Hospitalist Program.
Using Opioids in the Hospitalized Patient Nicole Artz, MD Assistant Professor of Medicine University of Chicago No financial relationships to disclose.
Aging Q3 Pain Management ACOVE  Pharmacological treatment with analgesics for pain is the most common in the elderly, however, the use of alternative medications.
Tom Waddell Urban Health Clinic: Patients Using Controlled Medicines* If you are taking controlled medicines, your safety is our highest priority! Our.
Jeanne Keen, RN, CADC Program Administrator. Opium Aunti, Big O Heroin H, Horse, Smack Morphine Dreamer, Morf, God’s Drug Codeine School Boy Oxycodone.
Treatment: other opioids Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Analgesics and Antipyretics
Buprenorphine {Suboxone®, Subutex®}
UCLA Brain Institute Outreach Adrina Kocharian and Rachel Oseas.
Opioid Management Training June Joint Commission Sentinel Event  Sentinel Event - A sentinel event is an unexpected occurrence involving death.
Safe Opioid Prescribing MedicinesDoseFrequencyRouteQuantity Morphine Sulphate MR 10mg tablets10mgBD OralSupply 28 tablets (Twenty eight tablets) Morphine.
GP Clinical Governance Meeting 13 th of July 2011 Dr Marion Lieth Consultant in Palliative Medicine, Bolton Hospital and Bolton Hospice Common issues:
Opioid Tapering Paul Coelho, MD David Tauben, MD Melissa Weimer, DO, MCR.
Opioids Tapering Melissa B. Weimer, DO, MCR. Disclosures Dr. Weimer is a consultant for INFORMed, IMPACT education, and the American Association of Addiction.
DEBBIE DONELSON, MD Opioid use for nonmalignant pain management.
Opiates.
Jena Torpin, Pharm.D. Mary Cunningham, APRN November 6, 2013
pink pill cor 135 street value
Objectives Palliative pain management in the ER : Basic approach
Watson 932 discontinued are oxycodone better than hydrocodone addiction oxycodone hcl vs oxycodone cr 10mg 10 mg oxycodone percocet highest milligram 100.
Opiod analgesics 9월 흉부외과 인턴 김영재.
Opiate Receptors in the body
Oxycodone a333 pill kind of percocet watson 932 oxycodone oxycodone 4839 mg golf how many 325 mg oxycodone to overdose oxycodone 30 mg discontinued.
street value of oxycodone 5 mg
Acute Pain Management Solomon Liao, M.D.
Palliative Care in the Outpatient Setting: Pain Management
Opiates Option D, Section 3.
STOP! Safe Treatment of Pain
Addressing sleep problems- The role of long-acting opioids
Opioids and other drugs we use in palliative care
Pain Management: Patients Maintained on Buprenorphine
Opioids.
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
Prescription Drug Monitoring Program
Safe and Appropriate Use of Opiates
Prescription Drug Monitoring Program
Calculating and Using Morphine Equivalent Doses of Opioids
Pain Management Top 10 Resident Pitfalls- 2019
Presentation transcript:

Cory Taylor, MD January 15, 2016

56 year-old veteran with obstructive sleep apnea presents with subacute abdominal pain. CT findings are concerning for gastric adenocarcinoma. The patient is complaining of 10/10 pain and the nurse wants to know what you would like to give him…

 Understand practical pharmacology behind selecting dose amounts and frequencies  Appreciate the different ways of making opioids available to patients  Bring balance to the Force and order to your opioid selection  Prepare for the possible respiratory side effects of opioid administration

 Onset: informs the dose amount  IV speed of onset (fastest-slowest)  Fentanyl ≈ Heroin : Dilaudid : Morphine  PO speed of onset (fastest-slowest)  Oxycodone ≈ Dilaudid : Morphine ≈ Hydrocodone ≈ Codeine*  IV time to max efficacy = 10 min  PO time to max efficacy = 60 min  Duration: informs the dose frequency  Dilaudid, Morphine, Hydrocodone, Oxycodone = 4 hours*  Practically Speaking… Opioids should be dosed at least Q4H to prevent gaps in the maintenance of pain control

 PRN or “As Needed” Dosing PROS  Patient triggered – they can only get what they ask for  Added layer of overdose protection  Set it and forget it – less thought, faster ordering CONS  Time to administration can take min depending on staff  Leads to coverage gaps, poorly controlled pain  Makes patient’s feel dependent, disempowered, or “seeking”  Creates nursing-patient tension => increased nursing stress  Overlooks altered or less verbal patients  Interferes with patient sleep

 Around-the-clock or “Scheduled” Dosing PROS  Better coverage, better control, better sleep  Patients are empowered – reduces patient/nursing tension  Easier on nursing workflow  Don’t need, don’t want: patients can always refuse CONS  Need holding parameters*  Dynamically inflexible with changes in metabolism or mental status  Takes more time and thought

 Basal-Breakthrough Dosing  ATC dose provides basal coverage  PRN dose covers breakthrough pain PROS  Less nursing pages  Better satisfaction scores CONS  More time ordering, thinking  Can increase demands on nursing staff*

 Enter the PCA Best of every world  Patient finally feels some control over their illness  Nursing can set and forget  Doctor can set and [sort-of] forget Responsiveness + Precision => Finesse  Smaller doses, greater frequencies, immediate delivery  Allows for precise and expeditious titration up or down  No coverage gaps  Streamlines opioid consolidation and conversion No safer alternative than Bolus-only PCA* CONS  Requires cognitive function and trigger-ability  Parenteral administration only

 # 1: Opioid Solidarity Stick to a single opioid type Less medication errors Easier for titration and conversion  # 2: Opioid Equivalency No one opioid activates receptors better than others Some opioids are more potent, but potency can be overcome by concentration But some patients will maintain that one opioid “works better for me” than another…

 Opioids are more like loop diuretics than antibiotics  With antibiotics, one may “cover” the patient’s infection where another fails  With opioids – Morphine : Lasix as Dilaudid : Bumex*  Consequences of sub-optimal utilization Can inadvertently reinforce drug-anchoring or drug- seeking behaviors Can detract from future encounters and therapeutic relationships

You give the patient an basal-breakthrough opioid regimen. Later on that night, the nurses calls to inform you the patient’s oxygen saturation is 80%. He wants to know if you should dial back on the opioids… See Notes Section for Discussion

 Not all opioid-related sleep is opioid narcosis  Opioid-induced narcosis produces resistant or refractory somnolence  Healthy opioid-related sleep in wake-able  Opioid overdose always leads to somnolence before respiratory failure  Respiratory failure is caused by decreased respiratory drive*  Keep in mind: respiratory rates of 8-10 are normal in healthy individuals

 Responsiveness to naloxone in altered mental status is not diagnostic for opioid-narcosis  Naloxone blocks the body’s natural endorphin- mediated suppression of pain Can cause pain and discomfort, even in healthy individuals Responsiveness to naloxone = responsiveness to noxious stimulus

 Morphine SR + percocet for breakthrough  Morphine IVP PRN for moderate pain + Dilaudid IVP PRN for severe pain  Fentanyl drip + oral dilaudid q6h as needed  Norco q4H ATC + Norco Q2H PRN  Oxycontin + tramadol

See additional slides for supplemental material*

EQUIANALGESIC DOSING GUIDELINES FOR CHRONIC PAIN CHANGING ROUTES OF ADMINISTRATION METHADONE PO/PRIV/SC/IMEpiduralIntrathecal Daily Morphine Dose (mg/24 hrs PO) Conversion Rates Morphine POMethadone PO < CHANGING ANALGESICS OPIOIDS Enteral Dose (Oral, Rectal) Analgesic Parenteral Dose (SC/IV/IM) Meperidine50> Tramadol-> Codeine50> Hydrocodone- 15Morphine5METHADONE SC DOSING 10Oxycodone-1. Convert from daily Morphine Equivalent PO Dose / 24 hrs to Methadone 5Oxymorphone- PO Dose / 24 hrs using the Methadone PO Dosing Table above 3Hydromorphone1 2. Then ÷ 2 to convert to Methadone SC Dose/24 hrs 2Levorphanol1 -Fentanyl0.050 mg*ADJUSTING FOR INCOMPLETE CROSS TOLERANCE *1000 mcg = 1 mg: must convert to mg to calculate equianalgesic doseComplete100% Near-complete75% TRANSDERMAL FENTANYLIncomplete33-50% Morphine 50 mg PO in 24 hrs ≈ Fentanyl 25 mcg transdermal patch q 72 hrs Ferris FD and Pirrello RD: Improving Equianalgesic Dosing for Chronic Pain Management, American Association for Cancer Education Annual Meeting, oral presentation, Cincinnati, Ohio, September 2005 These are guidelines only and do not replace clinical judgement. © International Programs, OhioHealth, Permission to reproduce material is granted for non-commercial educational purposes only, provided that the attribution statement and copyright are displayed To reproduce for all other purposes, contact The International Programs at or visit IPCRC.net

 Faster onset, time to peak, and other factors can increase the euphoria associated with a given opioid  Euphoria is sometimes mistakenly perceived by patients as increased efficacy => increased drug-anchoring/requesting behaviors Euphoria ~> dependency, STREET VALUE

 Not all aberrant behavior is drug-seeking behavior Traffickers are not always abusers  Desperate or anchoring behavior ≠ “drug- seeking” behavior Legitimate patients with undertreated pain or opioid withdrawal have genuine needs

 Negative or discordant urine drug screen  Inconsistency of story  Splitting  Provider-jumping  Losing prescriptions  Poor self-care or self- investment  Running out of medication  Haggling or making demands  Irrationality, especially regarding equivalent doses RED FLAGS YELLOW FLAGS